Pharma’s engagement with healthcare providers has slipped in recent years
Changing trends show a reduction in HCP contact with the pharma industry and an increased prioritisation of in-person contact.

Changing trends show a reduction in HCP contact with the pharma industry and an increased prioritisation of in-person contact.
The company aims to publish the first results from the trial next year.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Junshi publishes positive Phase III results for Covid-19 pill VV116
University of Queensland’s vaccine shows virus-neutralising effect in trial
AIM ImmunoTech concludes dosing in Phase II post-Covid drug trial
COP27: Have we committed to our goals?